Reviews Spiriva


No reviews yet.

Spiriva Drug Description
SPIRIVA® HandiHaler®
(tiotropium bromide inhalation powder) Capsules for Respiratory Inhalation
DRUG DESCRIPTION



What are the possible side effects of tiotropium inhalation (Spiriva)?

Stop using tiotropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

tongue swelling or redness;
sores or white patches of your mouth, lips, or tongue; or
urinating less than usual or not at all.

Less serious side effects may include:

...
Read All Potential Side Effects for Spiriva »




SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.
Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier.
The dry powder formulation within the SPIRIVA capsule is intended for oral inhalation only.
The active component of SPIRIVA HandiHaler is tiotropium. The drug substance,
tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic
receptors. It is chemically described as (1α, 2β, 4β, 5α,
7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
bromide monohydrate. It is a synthetic, non-chiral, quaternary ammonium compound.
Tiotropium bromide is a white or yellowish white powder. It is sparingly soluble
in water and soluble in methanol.
The structural formula is:








Tiotropium bromide (monohydrate) has a molecular mass of 490.4 and a molecular
formula of C19H22NO4S2Br•H2O.
The HandiHaler device is an inhalation device used to inhale the dry powder
contained in the SPIRIVA capsule. The dry powder is delivered from the HandiHaler
device at flow rates as low as 20 L/min. Under standardized in vitro
testing, the HandiHaler device delivers a mean of 10.4 mcg tiotropium when tested
at a flow rate of 39 L/min for 3.1 seconds (2 L total). In a study of 26 adult
patients with COPD and severely compromised lung function [mean FEV1
1.02 L (range 0.45 to 2.24 L); 37.6% of predicted (range 16% to 65%)], the median
peak inspiratory flow (PIF) through the HandiHaler device was 30.0 L/min (range
20.4 to 45.6 L/min). The amount of drug delivered to the lungs will vary depending
on patient factors such as inspiratory flow and peak inspiratory flow through
the HandiHaler device, which may vary from patient to patient, and may vary
with the exposure time of the SPIRIVA capsule outside the blister pack.Last reviewed on RxList: 1/5/2010




Spiriva Drug Description
SPIRIVA® HandiHaler®
(tiotropium bromide inhalation powder) Capsules for Respiratory Inhalation
DRUG DESCRIPTION



What are the possible side effects of tiotropium inhalation (Spiriva)?

Stop using tiotropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

tongue swelling or redness;
sores or white patches of your mouth, lips, or tongue; or
urinating less than usual or not at all.

Less serious side effects may include:

...
Read All Potential Side Effects for Spiriva »




SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.
Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier.
The dry powder formulation within the SPIRIVA capsule is intended for oral inhalation only.
The active component of SPIRIVA HandiHaler is tiotropium. The drug substance,
tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic
receptors. It is chemically described as (1α, 2β, 4β, 5α,
7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
bromide monohydrate. It is a synthetic, non-chiral, quaternary ammonium compound.
Tiotropium bromide is a white or yellowish white powder. It is sparingly soluble
in water and soluble in methanol.
The structural formula is:








Tiotropium bromide (monohydrate) has a molecular mass of 490.4 and a molecular
formula of C19H22NO4S2Br•H2O.
The HandiHaler device is an inhalation device used to inhale the dry powder
contained in the SPIRIVA capsule. The dry powder is delivered from the HandiHaler
device at flow rates as low as 20 L/min. Under standardized in vitro
testing, the HandiHaler device delivers a mean of 10.4 mcg tiotropium when tested
at a flow rate of 39 L/min for 3.1 seconds (2 L total). In a study of 26 adult
patients with COPD and severely compromised lung function [mean FEV1
1.02 L (range 0.45 to 2.24 L); 37.6% of predicted (range 16% to 65%)], the median
peak inspiratory flow (PIF) through the HandiHaler device was 30.0 L/min (range
20.4 to 45.6 L/min). The amount of drug delivered to the lungs will vary depending
on patient factors such as inspiratory flow and peak inspiratory flow through
the HandiHaler device, which may vary from patient to patient, and may vary
with the exposure time of the SPIRIVA capsule outside the blister pack.Last reviewed on RxList: 1/5/2010




Spiriva Drug Description
SPIRIVA® HandiHaler®
(tiotropium bromide inhalation powder) Capsules for Respiratory Inhalation
DRUG DESCRIPTION



What are the possible side effects of tiotropium inhalation (Spiriva)?

Stop using tiotropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

tongue swelling or redness;
sores or white patches of your mouth, lips, or tongue; or
urinating less than usual or not at all.

Less serious side effects may include:

...
Read All Potential Side Effects for Spiriva »




SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.
Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier.
The dry powder formulation within the SPIRIVA capsule is intended for oral inhalation only.
The active component of SPIRIVA HandiHaler is tiotropium. The drug substance,
tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic
receptors. It is chemically described as (1α, 2β, 4β, 5α,
7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
bromide monohydrate. It is a synthetic, non-chiral, quaternary ammonium compound.
Tiotropium bromide is a white or yellowish white powder. It is sparingly soluble
in water and soluble in methanol.
The structural formula is:








Tiotropium bromide (monohydrate) has a molecular mass of 490.4 and a molecular
formula of C19H22NO4S2Br•H2O.
The HandiHaler device is an inhalation device used to inhale the dry powder
contained in the SPIRIVA capsule. The dry powder is delivered from the HandiHaler
device at flow rates as low as 20 L/min. Under standardized in vitro
testing, the HandiHaler device delivers a mean of 10.4 mcg tiotropium when tested
at a flow rate of 39 L/min for 3.1 seconds (2 L total). In a study of 26 adult
patients with COPD and severely compromised lung function [mean FEV1
1.02 L (range 0.45 to 2.24 L); 37.6% of predicted (range 16% to 65%)], the median
peak inspiratory flow (PIF) through the HandiHaler device was 30.0 L/min (range
20.4 to 45.6 L/min). The amount of drug delivered to the lungs will vary depending
on patient factors such as inspiratory flow and peak inspiratory flow through
the HandiHaler device, which may vary from patient to patient, and may vary
with the exposure time of the SPIRIVA capsule outside the blister pack.Last reviewed on RxList: 1/5/2010




Spiriva Drug Description
SPIRIVA® HandiHaler®
(tiotropium bromide inhalation powder) Capsules for Respiratory Inhalation
DRUG DESCRIPTION



What are the possible side effects of tiotropium inhalation (Spiriva)?

Stop using tiotropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

tongue swelling or redness;
sores or white patches of your mouth, lips, or tongue; or
urinating less than usual or not at all.

Less serious side effects may include:

...
Read All Potential Side Effects for Spiriva »




SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.
Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier.
The dry powder formulation within the SPIRIVA capsule is intended for oral inhalation only.
The active component of SPIRIVA HandiHaler is tiotropium. The drug substance,
tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic
receptors. It is chemically described as (1α, 2β, 4β, 5α,
7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
bromide monohydrate. It is a synthetic, non-chiral, quaternary ammonium compound.
Tiotropium bromide is a white or yellowish white powder. It is sparingly soluble
in water and soluble in methanol.
The structural formula is:








Tiotropium bromide (monohydrate) has a molecular mass of 490.4 and a molecular
formula of C19H22NO4S2Br•H2O.
The HandiHaler device is an inhalation device used to inhale the dry powder
contained in the SPIRIVA capsule. The dry powder is delivered from the HandiHaler
device at flow rates as low as 20 L/min. Under standardized in vitro
testing, the HandiHaler device delivers a mean of 10.4 mcg tiotropium when tested
at a flow rate of 39 L/min for 3.1 seconds (2 L total). In a study of 26 adult
patients with COPD and severely compromised lung function [mean FEV1
1.02 L (range 0.45 to 2.24 L); 37.6% of predicted (range 16% to 65%)], the median
peak inspiratory flow (PIF) through the HandiHaler device was 30.0 L/min (range
20.4 to 45.6 L/min). The amount of drug delivered to the lungs will vary depending
on patient factors such as inspiratory flow and peak inspiratory flow through
the HandiHaler device, which may vary from patient to patient, and may vary
with the exposure time of the SPIRIVA capsule outside the blister pack.Last reviewed on RxList: 1/5/2010




Spiriva Drug Description
SPIRIVA® HandiHaler®
(tiotropium bromide inhalation powder) Capsules for Respiratory Inhalation
DRUG DESCRIPTION



What are the possible side effects of tiotropium inhalation (Spiriva)?

Stop using tiotropium inhalation and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

tongue swelling or redness;
sores or white patches of your mouth, lips, or tongue; or
urinating less than usual or not at all.

Less serious side effects may include:

...
Read All Potential Side Effects for Spiriva »




SPIRIVA HandiHaler consists of a capsule dosage form containing a dry powder formulation of tiotropium intended for oral inhalation only with the HandiHaler device.
Each light green, hard gelatin SPIRIVA capsule contains 18 mcg tiotropium (equivalent to 22.5 mcg tiotropium bromide monohydrate) blended with lactose monohydrate (which may contain milk proteins) as the carrier.
The dry powder formulation within the SPIRIVA capsule is intended for oral inhalation only.
The active component of SPIRIVA HandiHaler is tiotropium. The drug substance,
tiotropium bromide monohydrate, is an anticholinergic with specificity for muscarinic
receptors. It is chemically described as (1α, 2β, 4β, 5α,
7β)-7-[(Hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
bromide monohydrate. It is a synthetic, non-chiral, quaternary ammonium compound.
Tiotropium bromide is a white or yellowish white powder. It is sparingly soluble
in water and soluble in methanol.
The structural formula is:








Tiotropium bromide (monohydrate) has a molecular mass of 490.4 and a molecular
formula of C19H22NO4S2Br•H2O.
The HandiHaler device is an inhalation device used to inhale the dry powder
contained in the SPIRIVA capsule. The dry powder is delivered from the HandiHaler
device at flow rates as low as 20 L/min. Under standardized in vitro
testing, the HandiHaler device delivers a mean of 10.4 mcg tiotropium when tested
at a flow rate of 39 L/min for 3.1 seconds (2 L total). In a study of 26 adult
patients with COPD and severely compromised lung function [mean FEV1
1.02 L (range 0.45 to 2.24 L); 37.6% of predicted (range 16% to 65%)], the median
peak inspiratory flow (PIF) through the HandiHaler device was 30.0 L/min (range
20.4 to 45.6 L/min). The amount of drug delivered to the lungs will vary depending
on patient factors such as inspiratory flow and peak inspiratory flow through
the HandiHaler device, which may vary from patient to patient, and may vary
with the exposure time of the SPIRIVA capsule outside the blister pack.Last reviewed on RxList: 1/5/2010





Other reviews about Spiriva on wordpress

Spiriva
  by lioness321
We decided to give the Spiriva (tiotropium bromide) a try. I did find a few references to using it or other related medications in kids/teens for VCD […]


Long-Term Outcomes of Vocal Cord Dysfunction
  by lioness321
I found an encouraging article abstract today on the Long-term outcome of vocal cord dysfunction. Of 28 patients contacted 1 month to 5 years after diagnosis with VCD, only […]


The usual...
  by B
Boehringer Ingelheim and FDA notified healthcare professionals that ongoing safety monitoring has identified a possible increased risk of stroke in patients who take Spiriva. This product […]


Spiriva campaign gets All-Star debut
  by extensointel
Major League Baseball's annual All-Star Game last night featured new DTC spots for Spiriva HandiHaler, an inhaler indicated for chronic bronchitis and emphysema. The TV spot features an upper middle-aged […]


Spiriva Inhaler Approved To Reduce Flares of COPD
  by timeinctemp
FRIDAY, Dec. 18 (HealthDay News) — The U.S. Food and Drug Administration has expanded approval for the Spiriva Handihaler (tiotropium bromide inhalation powder) to include reducing symptoms during […]


Leading COPD Drug Won't Harm Heart: FDA
  by timeinctemp
 THURSDAY, Jan. 14 (HealthDay News) — The U.S. Food and Drug Administration on Thursday said it found no good evidence that the Spiriva HandiHaler boosts heart risks in […]


Drug Information Update: FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
  by neurologist
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug […]


Spiriva Safe, says the FDA
  by dundeechest
The mainstay of COPD management is bronchodilatation - the local, and national guidelines rely on beta-2 agonists, and anti-cholinergics.  Recent(ish) data from the TORCH study suggested that inhaled […]


Spiriva As Good As Serevent In Asthma Study
  by iesalem
LOS ANGELES (AP) — Researchers say they've found a possible new treatment for adults with hard-to-control asthma. A federally funded study found that Spiriva, which is used to treat […]


Spiriva (tiotropium) May Help Adults with Asthma
  by Dr. Mark
Spiriva (tiotropium) is an inhaled bronchodilator that is normally used for the treatment of emphysema or chronic bronchitis (COPD). It is categorized as a long-acting anticholinergic agent, in […]



Other reviews about Spiriva on web:

SPIRIVA HandiHaler is a once a day inhaled maintenance prescription treatment for breathing problems associated with COPD. SPIRIVA Home


Learn about the prescription medication Spiriva (Tiotropium Bromide), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Spiriva (Tiotropium Bromide) Drug Information: Uses, Side Effects ...


Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD. Includes Spiriva side effects, interactions and indications. Spiriva (tiotropium) Information from Drugs.com


Tiotropium (Spiriva) is a long-acting, 24 hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropium - Wikipedia, the free encyclopedia


Accurate, FDA approved Spiriva information for healthcare professionals and patients - brought to you by Drugs.com. Spiriva Official FDA information, side effects and uses.


SPIRIVA is a once-daily inhaled maintenance prescription treatment for chronic obstructive pulmonary disease (COPD). About SPIRIVA


Spiriva (tiotropium) is a bronchodilator medication used for maintenance treatment of COPD. Learn more with this complete guide to Spiriva. Spiriva - Complete Guide to Spiriva


On March 18, 2008, the FDA issued a statement warning people about a potentially fatal side effect of the COPD medication, Spiriva. Preliminary reports have indicated that this ... Spiriva - FDA Warning of Spiriva


Buy Spiriva (Tiotropium) from our Canadian Online Pharmacy by calling 1-877-888-3562. Fully licensed, fast delivery, free doctor consultation provided. Buy Spiriva (Tiotropium) Online Now


Tiotropium is a long-acting anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Tiotropiu... Spiriva: 658 user reviews - DailyStrength





Featured Reviews

Reviews Azithromycin

Zmax Drug Description Zmax® (azithromycin) Extended Release for Oral Suspension DRUG DESCRIPTION What are the possible side effects of azithromycin? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Pegademase Bovine

Adagen Drug Description ADAGEN® (pegademase bovine) Injection DRUG DESCRIPTION What are the possible side effects of pegademase bovine (Adagen)? If you experience any of the following serious side effects, stop using the pegademase...
Read More  |  Review This
Reviews Tindamax

Tindamax Drug Description Tindamax® (tinidazole) Tablets WARNING: POTENTIAL RISK FOR CARCINOGENICITY Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent (13.1)....
Read More  |  Review This
Reviews Cortisporin Cream

Cortisporin Cream Drug Description CORTISPORIN® Cream (neomycin and polymyxin B sulfates and hydrocortisone acetate) Cream, USP DRUG DESCRIPTION CORTISPORIN Cream (neomycin and polymyxin B sulfates and hydrocortisone acetate cream,...
Read More  |  Review This
Reviews Viracept

Viracept Drug Description VIRACEPT® (nelfinavir mesylate) Tablets and Oral Powder DRUG DESCRIPTION What are the possible side effects of nelfinavir (Viracept)? Get emergency medical help if you have any of these signs of an...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....